The Effects of Underrunning Water Bathing and Underrunning Water Bathing-Massage Combination on Bilirubin Levels in Term Newborns With Hyperbilirubinemia
2 other identifiers
interventional
90
1 country
1
Brief Summary
This randomized controlled study aimed to compare the effects of under running water bathing and underrunning water bathing combined with massage on bilirubin levels in term newborns receiving phototherapy. The study was conducted between June 2024 and March 2025 in the neonatal clinic of Kayseri City Hospital after obtaining institutional permission, ethics approval, and informed consent from the families. Ninety term newborns were randomly assigned to three groups:under running water bathing, under running water bathing +massage, and control (routine care). Bilirubin levels were measured before phototherapy and at the 12th and 24th hours. While bilirubin levels decreased over time in all groups, the underrunning water bathing combined massage group had significantly lower bilirubin levels than the control group at the 24th hour. The use of a underrunning water bath and massage combination is recommended as part of nursing care for term newborns receiving phototherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 6, 2025
CompletedFirst Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
August 19, 2026
CompletedAugust 19, 2026
January 1, 2026
9 months
March 16, 2026
August 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Serum Bilirubin Level Unit of Measure: mg/dL
Total serum bilirubin levels of term newborns receiving phototherapy will be measured to evaluate the effects of under-running water bathing and under-running water bathing combined with massage compared with a control group. Unit of Measure: mg/dL
Baseline (before initiation of phototherapy), 12 hours after initiation of phototherapy, and 24 hours after initiation of phototherapy
Secondary Outcomes (4)
Heart Rate-Unit of Measure: Beats/min.
T0 (baseline before initiation of phototherapy), T20 (20 minutes after baseline), T12 (12 hours after initiation of phototherapy), and T24 (24 hours after initiation of phototherapy).
Oxygen Saturation- Unıt of Measure %
T0 (baseline before initiation of phototherapy), T20 (20 minutes after baseline), T12 (12 hours after initiation of phototherapy), and T24 (24 hours after initiation of phototherapy).
Body Temperature-Unıt of Measure °C
T0 (baseline before initiation of phototherapy), T20 (20 minutes after baseline), T12 (12 hours after initiation of phototherapy) , and T24 (24 hours after initiation of phototherapy).
Respiratory Rate- Unıt of Measure Breaths/min
T0, T20, T12, and T24 .
Study Arms (3)
Underrunning Water Bathing Group
EXPERIMENTALTerm newborns receiving phototherapy will receive a underrunning water bathing before phototherapy as a nursing intervention.
Underrunning Water Bathing + Massage Group
EXPERIMENTALTerm newborns receiving phototherapy will receive a underrunning water bathing followed by massage before phototherapy.
Control Group
NO INTERVENTIONTerm newborns receiving phototherapy will receive routine clinical care without additional intervention.
Interventions
Following the baseline (T0) assessment, term newborns received an approximately 5-minute bath under running water as a supportive nursing intervention before the initiation of phototherapy. After the intervention, a second assessment of vital signs (T20) was performed, and phototherapy was subsequently initiated.Vital signs were reassessed at 12 and 24 hours after phototherapy initiation. Total serum bilirubin levels were measured at baseline (T0) and at 12 and 24 hours after phototherapy initiation.
Term newborns received a 5-minute bath under running water followed by a 15-minute massage as a supportive nursing intervention after the baseline (T0) assessment and before the initiation of phototherapy. Following the intervention, a second vital sign assessment (T20) was performed, phototherapy was subsequently initiated.Vital signs were reassessed at 12 and 24 hours after phototherapy initiation. Total serum bilirubin levels were measured at baseline (T0) and at 12 and 24 hours after phototherapy initiation.
Eligibility Criteria
You may qualify if:
- Term newborns with a gestational age between 38 and 42 weeks.
- Birth weight of 2500 g or higher.
- Newborns diagnosed with physiological hyperbilirubinemia.
- Newborns receiving phototherapy treatment.
- Postnatal age between 2 and 10 days.
- No congenital anomalies.
- No additional health problems.
- Apgar score ≥7 at the 1st minute after birth.
- Stable vital signs.
You may not qualify if:
- Birth weight ≤2500 g.
- Gestational age less than 38 weeks.
- Pathological jaundice (e.g., ABO incompatibility, Rh incompatibility, biliary atresia, glucose-6-phosphate dehydrogenase deficiency, or glucuronyl transferase enzyme deficiency).
- Inability to feed orally.
- Postnatal age on the first day of life.
- Receiving blood transfusion therapy.
- Newborns with secondary conditions such as asphyxia or infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bozok Universitylead
Study Sites (1)
Kayseri City Hospital, Neonatal Intensive Care Unit
Kayseri, Merkez, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşe ŞENER TAPLAK, Associate Professor, PhD
Yozgat Bozok Unıversty
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 16, 2026
First Posted
August 19, 2026
Study Start
June 17, 2024
Primary Completion
March 6, 2025
Study Completion
March 6, 2025
Last Updated
August 19, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to confidentiality concerns and institutional policies regarding data protection.